1. Home
  2. LAES vs TNGX Comparison

LAES vs TNGX Comparison

Compare LAES & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$4.16

Market Cap

366.0M

Sector

Technology

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$8.97

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
TNGX
Founded
2022
2014
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.0M
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LAES
TNGX
Price
$4.16
$8.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$6.00
$12.50
AVG Volume (30 Days)
14.4M
2.7M
Earning Date
12-11-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,978,000.00
$66,501,000.00
Revenue This Year
N/A
$53.01
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.29
52 Week Low
$1.48
$1.03
52 Week High
$11.00
$11.20

Technical Indicators

Market Signals
Indicator
LAES
TNGX
Relative Strength Index (RSI) 43.04 47.58
Support Level $4.45 $8.89
Resistance Level $5.09 $10.08
Average True Range (ATR) 0.37 0.61
MACD -0.01 -0.16
Stochastic Oscillator 23.71 8.07

Price Performance

Historical Comparison
LAES
TNGX

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: